Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
In July 2023, after receiving post-marketing reports of SI/B in patients taking GLP-1RA medications, the FDA initiated an investigation into whether there is an established link between the drugs and the psychiatric adverse events
The FDA has also warned that products labeled as for research purposes only or not for human consumption should not be purchased as they have unknown quality and might be harmful
Ichiro T, Katsuhiro A, Reiko K, Takuro S, Kazuhide T, Yuri H et al
Many people with Pernicious Anaemia face ongoing mental and emotional challenges because this condition affects the brain as much as the body
We further report a reduction in alcohol consumption in a cohort of people self-reporting alcohol use and taking Semaglutide or Tirzepatide compared to controls
The valuation was north of $500,000,000, indicating investor interest
.jpg)
